RPN2 and osteosarcoma: All the mice were evaluated for survival, and 143B-shRPN2-bearing mice showed longer survival than 143B-shNC-bearing mice (log-rank test, P = 0.020) (Figure 4e), suggesting that decreased RPN2 expression provided a survival advantage on osteosarcoma-bearing mice.